Tracy R E, Malcom G T, Oalmann M C, Newman W P, Guzman M A
Department of Pathology, Louisiana State University, New Orleans.
Mod Pathol. 1994 Apr;7(3):301-9.
Subjects dying of coronary heart disease (CHD) were compared with subjects in a control (basal) group in two series of forensic autopsies. Serum cholesterol assessed in postmortem heart blood was significantly greater in the CHD than in the basal group. CHD subjects were smokers more often than basal subjects, as determined from postmortem serum thiocyanate levels, but the statistical significance is ambiguous (P < 0.06). After exclusion of overt diabetics, a stepwise increase in the percentage of subjects with CHD was observed throughout the normal range for glycohemoglobin. Fibroplasia of small renal arteries, the most reliable postmortem proxy for hypertension, did not differ between CHD and basal groups. These results suggest that young (mean age 49.2 yr) black and white men and women classified from autopsy findings as having CHD as cause of death are often not hypertensive, but instead tend to be hyperlipidemic and glucose intolerant. A surprising result was that arteriolar hyalinization and arterial fibroplasia of the renal cortex often failed to parallel each other between groups of subjects. This was true in comparisons between black and white, male and female, blood cholesterol and glycohemoglobin groupings, and between CHD and basal subjects. This outcome suggests that hyalinization of renal arterioles is an especially reliable marker for CHD and that this association may not be mediated entirely through high blood pressure.
在两组法医尸检中,将死于冠心病(CHD)的受试者与对照组(基础组)的受试者进行了比较。通过检测死后心脏血液中的血清胆固醇发现,冠心病组的血清胆固醇水平显著高于基础组。根据死后血清硫氰酸盐水平测定,冠心病组受试者吸烟的比例高于基础组,但统计学意义不明确(P < 0.06)。排除明显的糖尿病患者后,在糖化血红蛋白的正常范围内,冠心病患者的比例呈逐步上升趋势。小肾动脉纤维增生是死后评估高血压最可靠的指标,冠心病组和基础组之间无差异。这些结果表明,从尸检结果分类为死于冠心病的年轻(平均年龄49.2岁)黑人和白人男性及女性,往往并非高血压患者,而是倾向于高脂血症和葡萄糖不耐受。一个令人惊讶的结果是,肾皮质的小动脉玻璃样变和动脉纤维增生在不同受试者组之间往往并不平行。在黑人和白人、男性和女性、血胆固醇和糖化血红蛋白分组之间以及冠心病组和基础组受试者之间的比较中都是如此。这一结果表明,肾小动脉玻璃样变是冠心病的一个特别可靠的标志物,并且这种关联可能并非完全通过高血压介导。